Research ArticleOriginal Article

EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation

Yang Chen, Youyou Wang, Lujun Zhao, Ping Wang, Jifeng Sun, Rudi Bao, Chenghai Li and Ningbo Liu
Cancer Biology & Medicine February 2018, 15 (1) 39-51; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0118

References

  1. 1.↵
    2. Singh D,
    3. Attri BK,
    4. Gill RK,
    5. Bariwal J.
    Review on EGFR inhibitors: critical updates. Mini Rev Med Chem. 2016; 16: 1134–66.
    OpenUrl
  2. 2.↵
    2. Eke I,
    3. Schneider L,
    4. Forster C,
    5. Zips D,
    6. Kunz-Schughart LA,
    7. Cordes N.
    EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Res. 2013; 73: 297–306.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    2. Yarden Y,
    3. Sliwkowski MX.
    Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001; 2: 127–37.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    2. Kasten-Pisula U,
    3. Saker J,
    4. Eicheler W,
    5. Krause M,
    6. Yaromina A,
    7. Meyer-Staeckling S, et al.
    Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification. Int J Radiat Oncol Biol Phys. 2011; 80: 1181–8.
    OpenUrlCrossRefPubMed
  5. 5.↵
    2. Siegel R,
    3. Ma JM,
    4. Zou ZH,
    5. Jemal A.
    Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9–29.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    2. Tyldesley S,
    3. Boyd C,
    4. Schulze K,
    5. Walker H,
    6. Mackillop WJ.
    Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001; 49: 973–85.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    2. Zhou L,
    3. He JZ,
    4. Xiong WJ,
    5. Liu YM,
    6. Xiang J,
    7. Yu Q, et al.
    Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: results of phase I dose-escalation study. Lung Cancer. 2016; 96: 93–100.
    OpenUrl
  8. 8.↵
    2. Kriegs M,
    3. Gurtner K,
    4. Can Y,
    5. Brammer I,
    6. Rieckmann T,
    7. Oertel R, et al.
    Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest. Radiother Oncol. 2015; 115: 120–7.
    OpenUrl
  9. 9.↵
    2. Xu P,
    3. Zhang WB,
    4. Cai XH,
    5. Qiu PY,
    6. Hao MH,
    7. Lu DD.
    Activating AKT to inhibit JNK by troxerutin antagonizes radiation-induced PTEN activation. Eur J Pharmacol. 2016; 795: 66–74.
    OpenUrl
  10. 10.↵
    2. Mondal A,
    3. Bennett LL.
    Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomed Pharmacother. 2016; 84: 1906–14.
    OpenUrl
  11. 11.↵
    2. Zhang D,
    3. Wang HB,
    4. Sun ME,
    5. Yang J,
    6. Zhang W,
    7. Han SX, et al.
    Speckle-type POZ protein, SPOP, is involved in the DNA damage response. Carcinogenesis. 2014; 35: 1691–7.
    OpenUrlCrossRefPubMed
  12. 12.↵
    2. Leatherbarrow EL,
    3. Harper JV,
    4. Cucinotta FA,
    5. O'Neill P.
    Induction and quantification of γ-H2AX foci following low and high LET-irradiation. Int J Radiat Biol. 2006; 82: 111–8.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    2. Sun XN,
    3. Yang CY,
    4. Liu H,
    5. Wang Q,
    6. Wu SX,
    7. Li X, et al.
    Identification and characterization of a small inhibitory peptide that can target DNA-PKcs autophosphorylation and increase tumor radiosensitivity. Int J Radiat Oncol Biol Phys. 2012; 84: 1212–9.
    OpenUrlPubMed
  14. 14.↵
    2. Hoshi H,
    3. Hiyama G,
    4. Ishikawa K,
    5. Inageda K,
    6. Fujimoto J,
    7. Wakamatsu A, et al.
    Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation. Oncol Rep. 2017; 37: 66–76.
    OpenUrl
  15. 15.↵
    2. Yu HA,
    3. Arcila ME,
    4. Rekhtman N,
    5. Sima CS,
    6. Zakowski MF,
    7. Pao W, et al.
    Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res. 2013; 19: 2240–7.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    2. Chong CR,
    3. Jänne PA.
    The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013; 19: 1389–400.
    OpenUrlCrossRefPubMed
  17. 17.↵
    2. Johnson ML,
    3. Riely GJ,
    4. Rizvi NA,
    5. Azzoli CG,
    6. Kris MG,
    7. Sima CS, et al.
    Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib. J Thorac Oncol. 2011; 6: 1128–31.
    OpenUrlCrossRefPubMed
  18. 18.↵
    2. Vansteenkiste J,
    3. De Ruysscher D,
    4. Eberhardt WE,
    5. Lim E,
    6. Senan S,
    7. Felip E, et al.
    Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24(Suppl 6): vi89–98.
    OpenUrlCrossRefPubMed
  19. 19.↵
    2. Provencio M,
    3. Sánchez A,
    4. Garrido P,
    5. Valcárcel F.
    New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin Lung Cancer. 2010; 11: 91–7.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    2. Chinnaiyan P,
    3. Huang S,
    4. Vallabhaneni G,
    5. Armstrong E,
    6. Varambally S,
    7. Tomlins SA, et al.
    Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res. 2005; 65: 3328–35.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    2. Ma H,
    3. Bi JP,
    4. Liu T,
    5. Ke Y,
    6. Zhang S,
    7. Zhang T.
    Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells. Oncol Rep. 2015; 33: 1161–70.
    OpenUrl
  22. 22.↵
    2. Wu YQ,
    3. Zhao D,
    4. Zhuang JB,
    5. Zhang FQ,
    6. Xu C.
    Caspase-8 and Caspase-9 functioned differently at different stages of the cyclic stretch-induced apoptosis in human periodontal ligament cells. PLoS One. 2016; 11: e0168268.
  23. 23.↵
    2. Srivastava SK,
    3. Bhardwaj A,
    4. Arora S,
    5. Tyagi N,
    6. Singh S,
    7. Andrews J, et al.
    MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and-independent pathways. Br J Cancer. 2015; 113: 660–8.
    OpenUrlCrossRefPubMed
  24. 24.↵
    2. Xu P,
    3. Cai XH,
    4. Zhang WB,
    5. Li YN,
    6. Qiu PY,
    7. Lu DD, et al.
    Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2(Ca2+)/Caspase-3/PARP-1 pathway. Apoptosis. 2016; 21: 1125–43.
    OpenUrlCrossRefPubMed
  25. 25.↵
    2. Yu L,
    3. Shang ZF,
    4. Hsu FM,
    5. Zhang Z,
    6. Tumati V,
    7. Lin YF, et al.
    NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. Oncotarget. 2015; 6: 3848–60.
    OpenUrl
  26. 26.↵
    2. Singh I,
    3. Ozturk N,
    4. Cordero J,
    5. Mehta A,
    6. Hasan D,
    7. Cosentino C, et al.
    High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX. Cell Res. 2015; 25: 837–50.
    OpenUrlCrossRefPubMed
  27. 27.↵
    2. Johansson P,
    3. Fasth A,
    4. Ek T,
    5. Hammarsten O.
    Validation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical applications. Cytometry Part B Clin Cytom. 2017; 92: 534–40.
    OpenUrl
  28. 28.↵
    2. Djuzenova CS,
    3. Elsner I,
    4. Katzer A,
    5. Worschech E,
    6. Distel LV,
    7. Flentje M, et al.
    Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci. Radiat Oncol. 2013; 8: 98.
    OpenUrl
  29. 29.↵
    2. Kinoshita E,
    3. van der Linden E,
    4. Sanchez H,
    5. Wyman C.
    RAD50, an SMC family member with multiple roles in DNA break repair: how does ATP affect function? Chromosome Res. 2009; 17: 277–88.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    2. Laffitte MCN,
    3. Leprohon P,
    4. Hainse M,
    5. Légaré D,
    6. Masson JY,
    7. Ouellette M.
    Chromosomal translocations in the parasite leishmania by a MRE11/RAD50-independent microhomology-mediated end joining mechanism. PLoS Genet. 2016; 12: e1006117.
  31. 31.↵
    2. Hohl M,
    3. Kwon Y,
    4. Galván SM,
    5. Xue XY,
    6. Tous C,
    7. Aguilera A, et al.
    The Rad50 coiled-coil domain is indispensable for Mre11 complex functions. Nat Struct Mol Biol. 2011; 18: 1124–31.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords